Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

Cardiologists lead push for new cath lab radiation safety standards
Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."
Pioneer cardiologist Amir Lerman remembered as a ‘true giant’ of the specialty
Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD.
CRT 2026: Key takeaways for interventional cardiologists
CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.
AI is transforming patient care—and cardiologists have a critical role to play
While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.
Next-generation guide extension catheter delivers value during complex PCI
The CrossFAST system was successfully used to deploy multiple stents after other devices fell short.

heart doctors and surgeons working together. top cardiology hospitals in the United States.

Cardiologists lead push for new cath lab radiation safety standards

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

Amir Lerman, MD, a veteran cardiologist with Mayo Clinic, died unexpectedly on Feb. 23. He was 69 years old.

Pioneer cardiologist Amir Lerman remembered as a ‘true giant’ of the specialty

Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD.

Several interventional cardiology late-breaking studies were presented at the Cardiovascular Research Technologies (CRT) 2026 meeting March 7-10, and experts from the Society of Society highlighted what they felt was most impactful to clinical practice. Photo by Dave Fornell.

CRT 2026: Key takeaways for interventional cardiologists

CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.

The Society for Cardiovascular Angiography and Interventions (SCAI) is urging federal policymakers to ensure physicians play a central role in guiding the integration of artificial intelligence (AI) into clinical care, while also raising questions about liability as the technology expands across healthcare.

AI is transforming patient care—and cardiologists have a critical role to play

While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.

Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated.

Next-generation guide extension catheter delivers value during complex PCI

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short.

artificial intelligence AI policy washington capitol

Cardiology groups to Trump administration: AI still has a long way to go

Multiple cardiology societies responded to an HHS request for public feedback by outlining some of the current barriers to wider AI adoption. "It is essential that any policy frameworks must reaffirm that clinicians—not algorithms—remain at the center of patient care," ACC President Christopher Kramer, MD, said.

SCAI celebrates new federal funding for PAD prevention

The group's hope is that these new funds will help address the rising rates of PAD and CLTI throughout the United States.

Image of the A-FLUX Reducer System for chest pain by VahatiCor

New heart device for ‘no-option’ chest pain patients shows early potential

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.